Brose Nils
Department of Molecular Neurobiology, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
Traffic. 2008 Sep;9(9):1403-13. doi: 10.1111/j.1600-0854.2008.00758.x. Epub 2008 Apr 28.
In contrast to constitutive secretion, SNARE-mediated synaptic vesicle fusion is controlled by multiple regulatory proteins, which determine the Ca(2+) sensitivity of the vesicle fusion process and the speed of excitation-secretion coupling. Complexins are among the best characterized SNARE regulators known to date. They operate by binding to trimeric SNARE complexes consisting of the vesicle protein synaptobrevin and the plasma membrane proteins syntaxin and SNAP-25. The question as to whether complexins facilitate or inhibit SNARE-mediated fusion processes is currently a matter of significant controversy. This is mainly because of the fact that biochemical experiments in vitro and studies on vertebrate complexins in vivo have yielded apparently contradictory results. In this review, I provide a summary of available data on the role of complexins in SNARE-mediated vesicle fusion and attempt to define a model of complexin function that incorporates evidence for both facilitatory and inhibitory roles of complexins in SNARE-mediated fusion.
与组成型分泌不同,SNARE介导的突触小泡融合受多种调节蛋白控制,这些蛋白决定了小泡融合过程对Ca(2+)的敏感性以及兴奋-分泌偶联的速度。复合体蛋白是迄今为止已被充分表征的SNARE调节蛋白之一。它们通过与由小泡蛋白突触小泡蛋白、质膜蛋白 syntaxin和SNAP-25组成的三聚体SNARE复合体结合来发挥作用。关于复合体蛋白是促进还是抑制SNARE介导的融合过程的问题,目前存在重大争议。这主要是因为体外生化实验和对脊椎动物复合体蛋白的体内研究得出了明显相互矛盾的结果。在这篇综述中,我总结了关于复合体蛋白在SNARE介导的小泡融合中作用的现有数据,并试图定义一个复合体蛋白功能模型,该模型纳入了复合体蛋白在SNARE介导的融合中促进和抑制作用的证据。